• Home  HOME
  • About  ABOUT US
  • About  PRODUCTS
  • Research  RESEARCH
  • Investors  INVESTOR RELATIONS
  • Contact  CONTACT
  • AFFILIATED WEBSITES
  • Contact
  •  ABOUT US
  • History
  •  PRODUCTS
  • USA
  • Canada
  • Israel
  • International
  •  INVESTOR RELATIONS
  • Investor Relations
  • Financials
  • Annual Reports
  • Fundamentals
  • Earnings & Proxy Reports
  • News Releases
  • Investor FAQ
  • E-mail Alerts
  • Contact Information
  • Safe Harbor
  • AFFILIATED WEBSITES
  • Taro Pharmaceutical Industries Ltd. Taro U.S.A
  • Taro Canada Taro Canada
  • Taro Israel Taro Israel
  • Taro International Taro International
  • Sun Pharmaceutical Ind. Ltd
  • Sun Pharmaceutical USA
  • Chattem Chemicals Inc.
Skip to main content

Taro Pharmaceutical Industries

  • WORLDWIDE SITES
      • USA
      • Canada
      • Israel
      • International
Text Size A A A

Lanso

Print Home » Lanso
Submitted by admin on Sat, 02/01/2014 - 13:54
Image: 
Product Type: 
RX
Active Ingredients: 
Lansoprazole
Strength: 
15mg, 30 mg
Dosage Form: 
Capsules
Therapeutic Activity: 
For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD

Category:

  • Gastro-Intestinal
Patient Information: 
http://abush.health.gov.il/units/pharmacy/Trufot/ShowAnonim.asp?TrCod=136%2047%2031242%2000&TrName=
  • Log in or register to post comments

Copyright © Taro Pharmaceutical Industries Ltd.  

Privacy Statement |  Terms of Use
Sitemap |  Site Credits